Published in Proc Natl Acad Sci U S A on March 15, 1991
Heparan sulfate proteoglycans of the cardiovascular system. Specific structures emerge but how is synthesis regulated? J Clin Invest (1997) 1.75
Abnormal patterns of lipoprotein lipase release into the plasma in GPIHBP1-deficient mice. J Biol Chem (2008) 1.73
Regulation of the synthesis, processing and translocation of lipoprotein lipase. Biochem J (1992) 1.30
Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J Clin Invest (1992) 1.16
Heparan sulfate expression in polarized epithelial cells: the apical sorting of glypican (GPI-anchored proteoglycan) is inversely related to its heparan sulfate content. J Cell Biol (1996) 1.15
Effects of heparin on the uptake of lipoprotein lipase in rat liver. BMC Physiol (2004) 1.09
Regulation of lipoprotein lipase activity and mRNA in the mammary gland of the lactating mouse. Biochem J (1994) 1.02
Deletion of the basement membrane heparan sulfate proteoglycan type XVIII collagen causes hypertriglyceridemia in mice and humans. PLoS One (2010) 0.94
Identification of a heparin-binding protein using monoclonal antibodies that block heparin binding to porcine aortic endothelial cells. Biochem J (1995) 0.94
Role of adipocyte-derived lipoprotein lipase in adipocyte hypertrophy. Nutr Metab (Lond) (2007) 0.88
Characterization of an atypical lipoprotein-binding protein in human aortic media membranes by ligand blotting. Biochem J (1994) 0.80
Muscle microvasculature's structural and functional specializations facilitate muscle metabolism. Am J Physiol Endocrinol Metab (2015) 0.77
PPARγ regulates expression of carbohydrate sulfotransferase 11 (CHST11/C4ST1), a regulator of LPL cell surface binding. PLoS One (2013) 0.75
Lipoprotein lipase. A multifunctional enzyme relevant to common metabolic diseases. N Engl J Med (1989) 3.31
Receptor-mediated transport of insulin across endothelial cells. Science (1985) 2.42
Lipolytic enzymes and plasma lipoprotein metabolism. Annu Rev Biochem (1980) 2.32
Cellular aspects of transcapillary exchange. Physiol Rev (1983) 2.10
Role of endothelial cell cytoskeleton in control of endothelial permeability. Circ Res (1982) 1.79
Endothelial monolayer permeability to macromolecules. Fed Proc (1987) 1.36
The response of lipoprotein lipase to feeding and fasting. Evidence for posttranslational regulation. J Biol Chem (1990) 1.32
Binding of lipoprotein lipase to endothelial cells in culture. J Biol Chem (1981) 1.31
Studies on inactivation of lipoprotein lipase: role of the dimer to monomer dissociation. Biochemistry (1985) 1.30
Lipoprotein lipase in myocytes and capillary endothelium of heart: immunocytochemical study. Am J Physiol (1989) 1.18
Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem (1989) 1.16
Effect of feeding and obesity on lipoprotein lipase activity, immunoreactive protein, and messenger RNA levels in human adipose tissue. J Clin Invest (1989) 1.14
Metabolism of endothelial cell-bound lipoprotein lipase. Evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J Biol Chem (1990) 1.09
Lipoprotein lipaseBethesda: a single amino acid substitution (Ala-176----Thr) leads to abnormal heparin binding and loss of enzymic activity. Proc Natl Acad Sci U S A (1990) 0.99
Two different mechanisms are involved in nutritional regulation of lipoprotein lipase in guinea-pig adipose tissue. Biochem J (1989) 0.95
Why fatty acids flow in cell membranes. Prog Lipid Res (1985) 0.94
Capillary transport of macromolecules: pores and other endothelial pathways. J Appl Physiol (1985) (1985) 0.93
Intracellular pathways of insulin transport across vascular endothelial cells. Am J Physiol (1988) 0.91
Active transendothelial transport of albumin. Interstitium to lumen. Circ Res (1985) 0.91
The comparative kinetics of soluble and heparin-Sepharose-immobilized bovine lipoprotein lipase. Arch Biochem Biophys (1983) 0.89
Lipid transfer between endothelial and smooth muscle cells in coculture. J Cell Physiol (1987) 0.88
Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim Biophys Acta (1990) 0.85
Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes (1988) 0.84
Proteins and vesicular transport in capillary endothelium. Fed Proc (1983) 0.83
Transendothelial albumin flux: evidence against asymmetric transport. J Appl Physiol (1985) (1986) 0.83
Tissue-specific overexpression of lipoprotein lipase causes tissue-specific insulin resistance. Proc Natl Acad Sci U S A (2001) 5.48
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Circulation (2000) 4.80
Structure-based analysis of catalysis and substrate definition in the HIT protein family. Science (1997) 2.27
Voltage-gated and calcium-gated calcium release during depolarization of skeletal muscle fibers. Biophys J (1991) 2.08
Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo. J Clin Invest (1986) 1.96
Antisense to cyclin D1 inhibits the growth and tumorigenicity of human colon cancer cells. Cancer Res (1997) 1.92
AHA Dietary Guidelines: revision 2000: A statement for healthcare professionals from the Nutrition Committee of the American Heart Association. Stroke (2000) 1.90
Identification of the female Japanese beetle sex pheromone: inhibition of male response by an enantiomer. Science (1977) 1.84
Calcium dependence of inactivation of calcium release from the sarcoplasmic reticulum in skeletal muscle fibers. J Gen Physiol (1991) 1.84
Time course of individual Ca2+ sparks in frog skeletal muscle recorded at high time resolution. J Gen Physiol (1999) 1.79
Numerical simulation of Ca2+ "sparks" in skeletal muscle. Biophys J (1999) 1.74
IP3 receptor: localization to plasma membrane of T cells and cocapping with the T cell receptor. Science (1992) 1.73
Direct visualization of lipid deposition and reverse lipid transport in a perfused artery : roles of VLDL and HDL. Circ Res (2000) 1.67
Modulation of the frequency of spontaneous sarcoplasmic reticulum Ca2+ release events (Ca2+ sparks) by myoplasmic [Mg2+] in frog skeletal muscle. J Gen Physiol (1998) 1.66
Lipoprotein lipase expression exclusively in liver. A mouse model for metabolism in the neonatal period and during cachexia. J Clin Invest (1998) 1.63
Macrophages and smooth muscle cells express lipoprotein lipase in human and rabbit atherosclerotic lesions. Proc Natl Acad Sci U S A (1991) 1.55
Repriming and activation alter the frequency of stereotyped discrete Ca2+ release events in frog skeletal muscle. J Physiol (1996) 1.47
Calcium transients and calcium homeostasis in adult mouse fast-twitch skeletal muscle fibers in culture. Am J Physiol (1997) 1.42
Three-dimensional structure of human protein kinase C interacting protein 1, a member of the HIT family of proteins. Proc Natl Acad Sci U S A (1996) 1.41
Lipoprotein metabolism during acute inhibition of hepatic triglyceride lipase in the cynomolgus monkey. J Clin Invest (1982) 1.39
Increased plasma and renal clearance of an exchangeable pool of apolipoprotein A-I in subjects with low levels of high density lipoprotein cholesterol. J Clin Invest (1993) 1.37
Sarcomeric calcium sparks activated by fiber depolarization and by cytosolic Ca2+ in skeletal muscle. Cell Calcium (1996) 1.31
Catalytically inactive lipoprotein lipase expression in muscle of transgenic mice increases very low density lipoprotein uptake: direct evidence that lipoprotein lipase bridging occurs in vivo. Proc Natl Acad Sci U S A (1998) 1.31
Lipoprotein lipase hydrolysis of retinyl ester. Possible implications for retinoid uptake by cells. J Biol Chem (1994) 1.31
Mammalian adipose tissue and muscle are major sources of lipid transfer protein mRNA. J Biol Chem (1991) 1.22
Sarco(endo)plasmic reticulum Ca2+ ATPase (SERCA) gene silencing and remodeling of the Ca2+ signaling mechanism in cardiac myocytes. Proc Natl Acad Sci U S A (2004) 1.21
Transcytosis of lipoprotein lipase across cultured endothelial cells requires both heparan sulfate proteoglycans and the very low density lipoprotein receptor. J Biol Chem (2000) 1.21
Lipoprotein lipase-mediated uptake and degradation of low density lipoproteins by fibroblasts and macrophages. J Clin Invest (1992) 1.20
Caffeine slows turn-off of calcium release in voltage clamped skeletal muscle fibers. Biophys J (1989) 1.20
Oligosaccharide sequences of endothelial cell surface heparan sulfate proteoglycan with affinity for lipoprotein lipase. J Biol Chem (1994) 1.20
Lipoprotein lipase expression level influences tissue clearance of chylomicron retinyl ester. J Lipid Res (1999) 1.17
Lipoprotein lipase increases low density lipoprotein retention by subendothelial cell matrix. J Clin Invest (1992) 1.16
Release of endothelial cell lipoprotein lipase by plasma lipoproteins and free fatty acids. J Biol Chem (1989) 1.16
Paradoxical increase in retinoblastoma protein in colorectal carcinomas may protect cells from apoptosis. Clin Cancer Res (1999) 1.15
Two mechanisms for termination of individual Ca2+ sparks in skeletal muscle. Proc Natl Acad Sci U S A (2000) 1.15
Calcium transients in intact rat skeletal muscle fibers in agarose gel. Am J Physiol (1995) 1.15
Genes for apolipoprotein B and microsomal triglyceride transfer protein are expressed in the heart: evidence that the heart has the capacity to synthesize and secrete lipoproteins. Circulation (1998) 1.14
Decay of calcium transients after electrical stimulation in rat fast- and slow-twitch skeletal muscle fibres. J Physiol (1997) 1.13
A mouse model with features of familial combined hyperlipidemia. Science (1997) 1.09
Metabolism of endothelial cell-bound lipoprotein lipase. Evidence for heparan sulfate proteoglycan-mediated internalization and recycling. J Biol Chem (1990) 1.09
Heparin-binding defective lipoprotein lipase is unstable and causes abnormalities in lipid delivery to tissues. J Clin Invest (2001) 1.08
Overexpression of apolipoprotein CII causes hypertriglyceridemia in transgenic mice. J Clin Invest (1994) 1.08
Lipoprotein lipase-mediated selective uptake from low density lipoprotein requires cell surface proteoglycans and is independent of scavenger receptor class B type 1. J Biol Chem (2000) 1.08
Lipoprotein lipase increases lipoprotein binding to the artery wall and increases endothelial layer permeability by formation of lipolysis products. Circ Res (1997) 1.07
Identification and characterization of the endothelial cell surface lipoprotein lipase receptor. J Biol Chem (1991) 1.05
Inositol 1,4,5-trisphosphate-mediated quantal Ca2+ release measured by high resolution imaging of Ca2+ within organelles. J Biol Chem (1993) 1.03
ApoA-I deficiency causes both hypertriglyceridemia and increased atherosclerosis in human apoB transgenic mice. J Lipid Res (1998) 1.01
Revision 2000: a statement for healthcare professionals from the Nutrition Committee of the American Heart Association. J Nutr (2001) 1.01
Statin inhibition of Fc receptor-mediated phagocytosis by macrophages is modulated by cell activation and cholesterol. Arterioscler Thromb Vasc Biol (2004) 1.01
Cellular differences in lipoprotein lipase-mediated uptake of low density lipoproteins. J Biol Chem (1994) 0.99
Streptozotocin-induced diabetes in human apolipoprotein B transgenic mice. Effects on lipoproteins and atherosclerosis. J Lipid Res (1999) 0.99
Clinical biochemistry in the hospital laboratory services. Lancet (1970) 0.98
Delayed catabolism of apoB-48 lipoproteins due to decreased heparan sulfate proteoglycan production in diabetic mice. J Clin Invest (2000) 0.98
Phenylephrine hypertrophy, Ca2+-ATPase (SERCA2), and Ca2+ signaling in neonatal rat cardiac myocytes. Am J Physiol Cell Physiol (2007) 0.98
Treatment of common lipoprotein disorders. Prog Cardiovasc Dis (1984) 0.98
Tight control of exogenous SERCA expression is required to obtain acceleration of calcium transients with minimal cytotoxic effects in cardiac myocytes. Circ Res (2001) 0.96
Association of plasma lipoproteins with postheparin lipase activities. J Clin Invest (1986) 0.95
Human ApoA-II inhibits the hydrolysis of HDL triglyceride and the decrease of HDL size induced by hypertriglyceridemia and cholesteryl ester transfer protein in transgenic mice. J Clin Invest (1994) 0.94
Disopyramide (Norpace)-induced hypoglycemia. Am J Med (1980) 0.92
Exogenous Ca2+-ATPase isoform effects on Ca2+ transients of embryonic chicken and neonatal rat cardiac myocytes. J Physiol (2000) 0.92
Black vomit after levodopa. Lancet (1971) 0.92
Identification of lipoprotein lipase immunoreactive protein in pre- and postheparin plasma from normal subjects and patients with type I hyperlipoproteinemia. J Lipid Res (1990) 0.92
Cytology of the lung in reference to irritant, individual sensitivity and healing. Acta Cytol (1971) 0.92
Improvement of plasma lipoprotein profiles during high-flux dialysis. J Am Soc Nephrol (1993) 0.92
Lipoprotein lipase regulates Fc receptor-mediated phagocytosis by macrophages maintained in glucose-deficient medium. J Clin Invest (1997) 0.91
Subendothelial retention of lipoprotein (a). Evidence that reduced heparan sulfate promotes lipoprotein binding to subendothelial matrix. J Clin Invest (1997) 0.91
Metabolism of apoprotein B in cynomolgus monkey: evidence for independent production of low-density lipoprotein apoprotein B. Am J Physiol (1983) 0.90
A public health model for cardiovascular risk reduction. Impact of cholesterol screening with brief nonphysician counseling. Arch Intern Med (1990) 0.90
Heparan sulfate proteoglycan-mediated uptake of apolipoprotein E-triglyceride-rich lipoprotein particles: a major pathway at physiological particle concentrations. Biochemistry (1997) 0.89
Lysolecithin-induced alteration of subendothelial heparan sulfate proteoglycans increases monocyte binding to matrix. J Biol Chem (1995) 0.88
Evidence for heterogeneity of low-density lipoprotein metabolism in the cynomolgus monkey. Biochim Biophys Acta (1986) 0.87
Perlecan mediates the antiproliferative effect of apolipoprotein E on smooth muscle cells. An underlying mechanism for the modulation of smooth muscle cell growth? J Biol Chem (1999) 0.87
Production and use of an inhibitory monoclonal antibody to human lipoprotein lipase. Biochim Biophys Acta (1986) 0.87
Lipoprotein lipase mRNA in neonatal and adult mouse tissues: comparison of normal and combined lipase deficiency (cld) mice assessed by in situ hybridization. J Lipid Res (1990) 0.87
Polarized binding of lipoprotein lipase to endothelial cells. Implications for its physiological actions. Arterioscler Thromb (1992) 0.87
Trace metal abnormalities in long-stay hyperactive mentally handicapped children and agitated senile dements. J R Soc Med (1986) 0.86
Identification of a heparin-releasable lipoprotein lipase binding protein from endothelial cells. J Biol Chem (1992) 0.86
Interaction of lipoprotein lipase with glycosaminoglycans and apolipoprotein C-II: effects of free-fatty-acids. Biochim Biophys Acta (1990) 0.85
Differentiated macrophages synthesize a heparan sulfate proteoglycan and an oversulfated chondroitin sulfate proteoglycan that bind lipoprotein lipase. Arterioscler Thromb Vasc Biol (1995) 0.85
Interaction between ApoB and hepatic lipase mediates the uptake of ApoB-containing lipoproteins. J Biol Chem (1998) 0.85
Mechanisms of increased lipoprotein lipase in fat cells of obese Zucker rats. Am J Physiol (1991) 0.84
Plasma lipolytic activity. Relationship to postheparin lipolytic activity and evidence for metabolic regulation. Diabetes (1988) 0.84
Lipoprotein lipase (LpL) affects low density lipoprotein (LDL) flux through vascular tissue: evidence that LpL increases LDL accumulation in vascular tissue. J Lipid Res (1994) 0.84
The heparin-binding proteins apolipoprotein E and lipoprotein lipase enhance cellular proteoglycan production. Arterioscler Thromb Vasc Biol (2000) 0.84
Distribution of gold in blood during chrysotherapy. Ann Clin Biochem (1978) 0.83
Endothelial cells and atherosclerosis: lipoprotein metabolism, matrix interactions, and monocyte recruitment. Curr Opin Lipidol (1994) 0.83
Plasma lipoprotein abnormalities associated with acquired hepatic triglyceride lipase deficiency. Metabolism (1985) 0.83
Release-activated Ca2+ transport in neurons of frog sympathetic ganglia. Neuron (1997) 0.83
Lipoprotein lipase enhances the interaction of low density lipoproteins with artery-derived extracellular matrix proteoglycans. J Lipid Res (1993) 0.83
Abnormal activation of lipoprotein lipase by non-equilibrating apoC-II: further evidence for the presence of non-equilibrating pools of apolipoproteins C-II and C-III in plasma lipoproteins. J Lipid Res (1993) 0.82
An amino-terminal fragment of apolipoprotein B binds to lipoprotein lipase and may facilitate its binding to endothelial cells. J Biol Chem (1994) 0.82
Trp64----nonsense mutation in the lipoprotein lipase gene. J Lipid Res (1992) 0.82
Distinct functions of protein kinase Calpha and protein kinase Cbeta during retinoic acid-induced differentiation of F9 cells. Cell Growth Differ (1998) 0.82
Tumor necrosis factor induced release of endothelial cell lipoprotein lipase. Arteriosclerosis (1990) 0.81
Lipoprotein lipase degradation by adipocytes: receptor-associated protein (RAP)-sensitive and proteoglycan-mediated pathways. J Lipid Res (1996) 0.81